Shay Capital LLC - 19 Sep 2025 SCHEDULE 13G Report for LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share (LVTX)

Filing Manager
Shay Capital LLC
Reporting Manager
Shay Capital LLC
Security
LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share
Symbol
LVTX
Shares outstanding
26,226,293 shares
Disclosed Ownership
2,596,403 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
26 Sep 2025, 16:01:22 UTC
Date of event
19 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Shay Capital LLC disclosed 9.9% ownership in LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share (LVTX) on 19 Sep 2025."

Quick Takeaways

  • Shay Capital LLC filed SCHEDULE 13G for LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share (LVTX).
  • Disclosed ownership: 9.9%.
  • Date of event: 19 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 26 Sep 2025, 16:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Shay Capital LLC 9.9% 2,596,403 2,596,403 0 Elan Foxman Chief Financial Officer
Shay Capital Holdings LLC 9.9% 2,596,403 2,596,403 0 Elan Foxman Chief Financial Officer

Sponsored